Skip to content
lifestyle.latabloid.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Gain Therapeutics, Inc.
Gain Therapeutics to Attend the 2026 Maxim Growth Summit
October 8, 2026
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration
October 1, 2026
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
September 29, 2026
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
September 17, 2026
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
August 25, 2026
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
August 11, 2026
Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update
May 22, 2026
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
May 19, 2026
Gain Therapeutics to Present at the 38th Annual ROTH Conference
March 19, 2026
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026